Veracyte | VCYT - Los Gastos De Explotación

Precio De Mercado
33.26
Cambio Diario
-0.22 -0.66%
Mensual
-8.32%
Anual
4.66%
Q1 Expectativa
31.16




Los Gastos De Explotación Cambio Fecha
Agenus USD -274.14M 80.46M 2025-09
Agilent USD 1.44B 27M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
Bruker USD 900.9M 124.3M 2025-12
Exact Sciences USD 875.74M 62.51M 2025-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Illumina USD 903M 69M 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Myriad Genetics USD 229M 3.4M 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Siemens EUR 16.57B 2.29B 2025-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Veracyte USD 116M 7.24M 2025-12
Waters USD 661.85M 1.67B 2025-12